As a Novel Prognostic Marker, Cysteine/histidine-rich 1 (CYHR1) is a Therapeutic Target in Patients with Esophageal Squamous Cell Carcinoma.
Desaki R, Sawada G, Okumura H, Ikeda R, Tanabe K, Komatsu H, Mimori K, Mori M, Kita Y, Uchikado Y, Arigami T, Uenosono Y, Owaki T, Ishigami S, Natsugoe S.
Desaki R, et al. Among authors: mimori k.
Ann Surg Oncol. 2017 Feb;24(2):586-593. doi: 10.1245/s10434-015-5031-0. Epub 2015 Dec 16.
Ann Surg Oncol. 2017.
PMID: 26676980